Huang James 4

4 · Connect Biopharma Holdings Ltd · Filed Jun 2, 2026

AI-generated summary of this filing

Updated Jun 2, 2026

Connect Biopharma (CNTB) Director James Huang Buys 150,000 Shares

What Happened

James Huang, a director of Connect Biopharma Holdings Ltd (CNTB), acquired 150,000 ordinary shares in open-market purchases on May 29, 2026. The reported weighted-average price was $2.48 per share, for a total reported value of $371,610.
This transaction is a purchase (insider acquisition), which investors often pay closer attention to than routine sales; the filing itself does not state Huang’s personal motivation.

Key Details

Transaction date: 2026-05-29; Form 4 filed: 2026-06-02 (Accession: 0001193125-26-253607).
Shares purchased: 150,000; weighted-average price: $2.48; total reported value: $371,610.
Price range: purchases occurred in multiple trades between $2.37 and $2.52 (footnote F1). The filer offers to provide breakdowns of quantities at each price on request.
Record/beneficial ownership note (footnote F2): Panacea Venture Healthcare Fund II, L.P. is the record holder of the shares. James Huang is the sole owner of entities that control the fund’s GP, so he may be deemed to share beneficial ownership but disclaims such ownership.
Shares owned after the transaction: not specified in this Form 4.

Context

The purchase was reported as fund-held (Panacea Venture Healthcare Fund II, L.P.) rather than direct registered ownership; this is common when insiders trade through investment vehicles they control. The filing’s footnotes explain the ownership chain and the weighted-average pricing across multiple trades.

Form 4

Period: 2026-05-29

Director

Transactions

Purchase
Ordinary Shares
[F1][F2]
2026-05-29$2.48/sh+150,000$371,610→ 13,310,000 total(indirect: See Footnote)

Footnotes (2)

[F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $2.37 to $2.52, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.
[F2]Panacea Venture Healthcare Fund II, L.P. is the record holder of the Ordinary Shares reported herein. James Huang is the sole owner of Panacea Innovation Limited, which is the sole owner of Panacea Venture Healthcare Fund II GP Company, Ltd., which is the general partner of Panacea Venture Healthcare Fund II, L.P. As a result, James Huang may be deemed to share beneficial ownership of the Ordinary Shares reported herein, but disclaims such beneficial ownership.

Signature

/s/ James Huang|2026-06-02

1 file